PMPRB Report Confirms Need for a Refocus on Optimal Drug Therapy
A study released by the Patented Medicine Prices Review Board confirms what Canada’s front-line pharmacists have been witnessing for years - while governments are achieving their goal of reducing drug prices and increasing the utilization of lower cost generic drugs, these actions are not leading to an improvement in drug therapy quality or value for Canadians.